Editorial: Host Innate Immunity Reaches the Clinic—The Laboratory of Genetics and Physiology Protein 2 (LGP2) Q425R Variant and Severity of Chronic Hepatitis Delta
Edoardo G. Giannini, Andrea Pasta. Editorial: Host Innate Immunity Reaches the Clinic—The Laboratory of Genetics and Physiology Protein 2 (LGP2) Q425R Variant and Severity of Chronic Hepatitis Delta. // Alimentary Pharmacology and Therapeutics. – 2026. – DOI: 10.1111/apt.71039. – URL: https://onlinelibrary.wiley.com/doi/10.1111/apt.71039?af=R
Edoardo G. Giannini & Andrea Pasta (2026). Editorial: Host Innate Immunity Reaches the Clinic—The Laboratory of Genetics and Physiology Protein 2 (LGP2) Q425R Variant and Severity of Chronic Hepatitis Delta. Alimentary Pharmacology and Therapeutics. https://doi.org/10.1111/apt.71039
Edoardo G. Giannini and Andrea Pasta. “Editorial: Host Innate Immunity Reaches the Clinic—The Laboratory of Genetics and Physiology Protein 2 (LGP2) Q425R Variant and Severity of Chronic Hepatitis Delta.” Alimentary Pharmacology and Therapeutics, 2026. doi:10.1111/apt.71039.
@article{Giannini2026,
title = {Editorial: Host Innate Immunity Reaches the Clinic—The Laboratory of Genetics and Physiology Protein 2 (LGP2) Q425R Variant and Severity of Chronic Hepatitis Delta},
author = {Giannini, Edoardo G. and Pasta, Andrea},
journal = {Alimentary Pharmacology and Therapeutics},
year = {2026},
doi = {10.1111/apt.71039},
url = {https://onlinelibrary.wiley.com/doi/10.1111/apt.71039?af=R}
}